SOD1 and myeloid sarcoma: In MS, CoQ-treated patients (500 mg/day) were found to have significant elevations in SOD activity and plasma total antioxidant capacity (TAC) and reductions in MDA levels in comparison to the placebo control group, suggesting that CoQ can increase the activity of antioxidant enzymes and reduce oxidative stress in patients with MS [119].